AKO Capital Grifols Sa Transaction History

Ako Capital LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$15.4 - $20.16 $189 Million - $247 Million	-12,273,278 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$18.24 - $21.45 $17.7 Million - $20.8 Million	-968,555 Reduced 7.31%	12,273,278 $224 Million
Q1 2020 May 06, 2020	BUY	$16.28 - $25.63 $13.6 Million - $21.4 Million	835,287 Added 6.73%	13,241,833 $267 Million
Q4 2019 Feb 13, 2020	BUY	$19.57 - $23.52 $4.83 Million - $5.81 Million	246,903 Added 2.03%	12,406,546 $289 Million
Q3 2019 Nov 06, 2019	SELL	$19.85 - $22.76 $8.01 Million - $9.18 Million	-403,280 Reduced 3.21%	12,159,643 $244 Million

Q2 2019 Aug 05, 2019	BUY	$17.59 - $21.1 $11.5 Million - $13.8 Million	654,497 Added 5.5%	12,562,923 $265 Million
Q1 2019 May 08, 2019	SELL	$18.01 - $20.11 $6.75 Million - $7.54 Million	-375,047 Reduced 3.05%	11,908,426 $239 Million
Q4 2018 Feb 06, 2019	BUY	$17.44 - $21.53 $42.5 Million - $52.5 Million	2,436,502 Added 24.74%	12,283,473 $226 Million
Q3 2018 Nov 06, 2018	SELL	$19.97 - $21.96 $18.2 Million - $20 Million	-912,666 Reduced 8.48%	9,846,971 $210 Million
Q2 2018 Aug 09, 2018	SELL	$20.16 - $24.68 $17.9 Million - $22 Million	-889,997 Reduced 7.64%	10,759,637 $231 Million
Q1 2018 May 02, 2018	BUY	$20.31 - $24.95 $6.03 Million - $7.41 Million	296,973 Added 2.62%	11,649,634 $247 Million
Q4 2017 Feb 02, 2018	SELL	$20.99 - $23.89 $2.35 Million - $2.67 Million	-111,899 Reduced 0.98%	11,352,661 $15.6 Million
Q3 2017 Nov 06, 2017	BUY	$20.07 - $21.89 $230 Million - $251 Million	11,464,560	11,464,560 $8.9 Million

150

140M

3.54M

919K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.51B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Ako Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Ako Capital LLP and Ako Capital with notifications on news.